Senior Investigator Profile

First NameNicholas
Award StatusTerm 2
Current PostConsutant in Respiratory Medicine
DepartmentResearch and Development
Telephone01223 336744
InstitutionPapworth Hospital NHS Foundation Trust
NHS TrustPapworth Hospital NHS Foundation Trust
Region NameEast of England
Primary Research FieldCardiology & Cardiovascular Disease
Secondary Research FieldRespiratory Diseases
BiographyNick Morrell qualified in Medicine (MB BS) from Charing Cross and Westminster Medical School (now Imperial College) in 1987. He undertook his research MD at Charing Cross and then spent 2 years in Denver, Colorado, as a British Heart Foundation Fellow before returning as a Lecturer to complete training in General and Respiratory Medicine at the Royal Postgraduate Medical School, Hammersmith Hospital. He was appointed Senior Lecturer and Honorary Consultant at Hammersmith Hospital, Imperial College in 1998 and was awarded an MRC Clinician Scientist Fellowship. He moved to Cambridge in 2000 as University Lecturer and Honorary Consultant at Addenbrooke's and Papworth Hospitals, and was appointed Professor of Cardiopulmonary Medicine in 2007. In 2009 he was awarded a British Heart Foundation Professorship and was elected to the Fellowship of the Academy of Medical Sciences in 2011. He has chaired the programme committees of the British and American Thoracic Societies (PC Assembly). He is a member of the MRC Clinical Fellowships Committee. He is Director of the BHF Cambridge Centre for Cardiovascular Research Excellence and leads the Cardiovascular Theme of the NIHR Cambridge Biomedical Research Centre. He is the Research Director of the Pulmonary Vascular Diseases Unit at Papworth Hospital. His research focuses on understanding genetic causes of cardiovascular disease, particularly pulmonary arterial hypertension, and developing new treatments for these conditions. He leads the MRC/BHF UK National Cohort Study of Idiopathic and Heritable Pulmonary Arterial Hypertension (NAIAD study) which is looking to determine the genetic basis of pulmonary arterial hypertension and the environmental factors that contribute to disease initiation and progression.

View CV 

<< Search SI Directory